Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Orthofix Medical (OFIX) Capital Expenditures (2016 - 2026)

Orthofix Medical has reported Capital Expenditures over the past 17 years, most recently at $10.7 million for Q1 2026.

For the quarter ending Q1 2026, Capital Expenditures rose 58.27% year-over-year to $10.7 million, compared with a TTM value of $38.6 million through Mar 2026, up 25.19%, and an annual FY2025 reading of $34.6 million, down 0.72% over the prior year.
Capital Expenditures came in at $10.7 million for Q1 2026, down from $10.9 million in the prior quarter.
In the past five years, Capital Expenditures ranged from a high of $21.9 million in Q3 2023 to a low of $5.1 million in Q3 2022.
Median Capital Expenditures over the past 5 years was $9.7 million (2024), compared with a mean of $9.7 million.
The sharpest move saw Capital Expenditures surged 326.6% in 2023, then tumbled 73.43% in 2024.
Over 5 years, Capital Expenditures stood at $7.0 million in 2022, then skyrocketed by 133.61% to $16.4 million in 2023, then tumbled by 47.84% to $8.5 million in 2024, then grew by 27.5% to $10.9 million in 2025, then decreased by 1.99% to $10.7 million in 2026.
Per Business Quant, the three most recent readings for OFIX's Capital Expenditures are $10.7 million (Q1 2026), $10.9 million (Q4 2025), and $9.9 million (Q3 2025).